Atorvastatin
Atorvastatin
CLINICAL USE
Hyperlipidaemia and hypercholesterolaemia
DOSE IN NORMAL RENAL FUNCTION
10–80 mg daily
PHARMACOKINETICS
Molecular weight                           :558.6 (1209.4 as calcium salt) %Protein binding                           :>98 %Excreted unchanged in urine     : Negligible Volume of distribution (L/kg)       :381 litreshalf-life – normal/ESRD (hrs)      :14 (active metabolite 20–30)/Unchanged DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in normal renal function HD                     :Not dialysed. Dose as in normal renal functionHDF/high flux   :Unknown dialysability. Dose as in normal renal functionCAV/VVHD      :Not dialysed. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAntibacterials: erythromycin, clarithromycin or fusidic acid possibly increased risk of myopathy; concentration increased by clarithromycin – do not exceed 20 mg of atorvastatin;1 avoid concomitant use with telithromycin; increased risk of myopathy with daptomycin. Anticoagulants: may transiently reduce anticoagulant effect of warfarinAntifungals: increased risk of myopathy with itraconazole – do not exceed 40 mg of atorvastatin,1 posaconazole and possibly other imidazoles and triazoles – avoid concomitant useAntivirals: increased risk of myopathy with amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir or saquinavir; concentration reduced by efavirenzCiclosporin: increased risk of myopathy – do not exceed 10 mg of atorvastatin.Lipid lowering agents: increased risk of myopathy with fibrates, gemfibrozil (avoid) and nicotinic acid ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
–Comments
– OTHER INFORMATION
Rhabdomyolysis with renal dysfunction secondary to myoglobinaemia has been reported with other statins
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home